Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gordon River Capital is a specialized investment management firm focused on the global healthcare and life sciences sectors. Founded by Dr. Craig Gordon, a former portfolio manager at Jennison Associates, the firm employs a fundamental, research-driven approach to identify investment opportunities across various healthcare sub-sectors. These include biotechnology, pharmaceuticals, and medical technology. The firm leverages deep clinical and scientific expertise to manage capital on behalf of institutional and private clients. By focusing on rigorous analysis of clinical data and market dynamics, Gordon River Capital aims to generate superior returns through high-conviction investments. The firm maintains a presence in both Florida and New York to support its research and operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gordon River Capital.